Developing Analytics to support Gene therapy AAV vectors

Showing results for 
Search instead for 
Did you mean: 

Developing Analytics to support the Next Generation of Gene Therapies

Team TFS
Team TFS

Gene therapy using adeno-associated virus (AAV) vectors is a rapidly emerging field, with many treatments in development and two recent FDA approvals. In this webinar, we will discuss the development of fast anion exchange chromatography methods for the analysis of full and empty AAV capsids. Baseline separation of full and empty capsids of several different serotypes using either salt gradient or pH gradient methods will be presented.


Key Learning Objectives:

  • Learn about AAV vectors growth in biotherapeutics
  • Learn about ways to analyze adeno-associated virus vectors
  • See method development using AEX method analyzing both full and empty AAV capsids


Who Should Attend:

  • Research Scientists
  • Application Scientists from Biopharma companies working on or interested in gene therapy
  • PhD students in any field of biotherapeutic drug development
  • Scientists looking to advance knowledge of gene therapy

Register here

Version history
Last update:
‎08-04-2022 09:00 AM
Updated by: